Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Mar-24 4:17 PM View:  | Apellis Pharmaceuticals, Inc. (APLS) | 13-Mar-24 | Private Sale | 11,220 | $57.56 | $645,838.00 | (17%) 67.51K to 56.29K | |
| 31-Jan-24 4:31 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 29-Jan-24 | Private Sale | 835 | $64.14 | $53,555.40 | (1%) 68.34K to 67.51K | |
| 23-Jan-24 6:11 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Jan-24 | Private Sale | 2,593 | $65.00 | $168,535.00 | (4%) 70.94K to 68.34K | |
| 17-Jan-24 4:40 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Grant | 19,508 | -- | -- | 37% 53.28K to 72.79K | |
| 17-Jan-24 4:40 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Sale | 1,857 | $66.81 | $124,064.00 | (3%) 72.79K to 70.94K | |
| 19-Sep-23 5:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 18-Sep-23 | Option Exercise | 9,719 | $29.76 | $289,237.00 | 15% 63.91K to 73.63K | |
| 19-Sep-23 5:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 18-Sep-23 | Option Sale | 9,719 | $44.27 | $430,221.00 | (13%) 73.63K to 63.91K | |
| 19-Sep-23 5:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 18-Sep-23 | Sale | 10,631 | $44.27 | $470,592.00 | (17%) 63.91K to 53.28K | |
| 22-Feb-23 6:45 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Grant | 9,886 | -- | -- | 18% 54.44K to 64.33K | |
| 22-Feb-23 6:45 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Payment of Exercise | 825 | $58.50 | $48,262.50 | (1%) 64.33K to 63.5K | |
| 30-Jan-23 5:02 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Jan-23 | Payment of Exercise | 551 | $52.77 | $29,076.30 | (1%) 54.99K to 54.44K | |
| 24-Jan-23 5:21 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Jan-23 | Payment of Exercise | 2,034 | $52.05 | $105,870.00 | (4%) 57.03K to 54.99K | |
| 17-Jan-23 7:41 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 12-Jan-23 | Grant | 22,580 | -- | -- | 66% 34.45K to 57.03K | |
| 17-Jan-23 7:41 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 25-Apr-22 | Disposition (other) | 1,875 | -- | -- | (5%) 35.55K to 33.68K | |
| 01-Feb-22 6:06 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-22 | Payment of Exercise | 650 | $38.59 | $25,083.50 | (2%) 36.2K to 35.55K | (15%) |
| 25-Jan-22 4:51 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Jan-22 | Grant | 26,051 | -- | -- | 257% 10.15K to 36.2K | |
| 01-Feb-21 4:38 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-21 | Grant | 9,375 | -- | -- | 100% 0 to 9.38K |